Comment
doi: 10.1016/j.biopsych.2017.01.010.
Orexin/Hypocretin, Central Amygdala, and Escalation of Cocaine Intake
Affiliations
- PMID: 28283054
- PMCID: PMC5798002
- DOI: 10.1016/j.biopsych.2017.01.010
Item in Clipboard
Comment
Orexin/Hypocretin, Central Amygdala, and Escalation of Cocaine Intake
Biol Psychiatry.
.
No abstract available
Conflict of interest statement
The authors report no biomedical financial interests or potential conflicts of interest.
Comment on
-
Hypocretin Neurotransmission Within the Central Amygdala Mediates Escalated Cocaine Self-administration and Stress-Induced Reinstatement in Rats.Biol Psychiatry. 2017 Apr 1;81(7):606-615. doi: 10.1016/j.biopsych.2016.06.010. Epub 2016 Jun 16. Biol Psychiatry. 2017. PMID: 27567312 Free PMC article.
Similar articles
-
Hypocretin/Orexin regulation of dopamine signaling and cocaine self-administration is mediated predominantly by hypocretin receptor 1.ACS Chem Neurosci. 2015 Jan 21;6(1):138-46. doi: 10.1021/cn500246j. Epub 2014 Dec 11. ACS Chem Neurosci. 2015. PMID: 25496218 Free PMC article.
-
Involvement of orexin-A in the regulation of neuronal activity and emotional behaviors in central amygdala in rats.Neuropeptides. 2020 Apr;80:102019. doi: 10.1016/j.npep.2020.102019. Epub 2020 Jan 16. Neuropeptides. 2020. PMID: 31980205
-
Hypocretin Neurotransmission Within the Central Amygdala Mediates Escalated Cocaine Self-administration and Stress-Induced Reinstatement in Rats.Biol Psychiatry. 2017 Apr 1;81(7):606-615. doi: 10.1016/j.biopsych.2016.06.010. Epub 2016 Jun 16. Biol Psychiatry. 2017. PMID: 27567312 Free PMC article.
-
[Involvement of orexins/hypocretins in multiple physiological functions].J UOEH. 2001 Jun 1;23(2):147-59. doi: 10.7888/juoeh.23.147. J UOEH. 2001. PMID: 11431960 Review. Japanese.
-
Neuropeptides controlling energy balance: orexins and neuromedins.Handb Exp Pharmacol. 2012;(209):77-109. doi: 10.1007/978-3-642-24716-3_4. Handb Exp Pharmacol. 2012. PMID: 22249811 Free PMC article. Review.
Cited by
-
Introduction to the Special Issue: "Making orexin-based therapies for addiction a reality: What are the steps from here?".Brain Res. 2020 Mar 15;1731:146665. doi: 10.1016/j.brainres.2020.146665. Epub 2020 Jan 10. Brain Res. 2020. PMID: 31930996 Free PMC article. No abstract available.
-
New directions in modelling dysregulated reward seeking for food and drugs.Neurosci Biobehav Rev. 2022 Jan;132:1037-1048. doi: 10.1016/j.neubiorev.2021.10.043. Epub 2021 Nov 2. Neurosci Biobehav Rev. 2022. PMID: 34736883 Free PMC article. Review.
-
Demand elasticity predicts addiction endophenotypes and the therapeutic efficacy of an orexin/hypocretin-1 receptor antagonist in rats.Eur J Neurosci. 2019 Aug;50(3):2602-2612. doi: 10.1111/ejn.14166. Epub 2018 Oct 14. Eur J Neurosci. 2019. PMID: 30240516 Free PMC article.
-
The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse.Neuropharmacology. 2021 Feb 1;183:108359. doi: 10.1016/j.neuropharm.2020.108359. Epub 2020 Oct 19. Neuropharmacology. 2021. PMID: 33091458 Free PMC article. Review.
-
Increased Number and Activity of a Lateral Subpopulation of Hypothalamic Orexin/Hypocretin Neurons Underlies the Expression of an Addicted State in Rats.Biol Psychiatry. 2019 Jun 1;85(11):925-935. doi: 10.1016/j.biopsych.2018.07.022. Epub 2018 Aug 7. Biol Psychiatry. 2019. PMID: 30219208 Free PMC article.
References
-
- Ahmed SH, Koob GF. Transition from moderate to excessive drug intake: Change in hedonic set point. Science. 1998;282:298–300. - PubMed
-
- Ahmed SH. The science of making drug-addicted animals. Neuroscience. 2012;211:107–125. - PubMed
-
- Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 2001;24:97–129. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
